Epithelial tight junction proteins as potential antibody targets for pancarcinoma therapy

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Cancer Immunology and Immunotherapy

• Publication date

  2005-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00262-004-0613-xPMID 15750830PMCID PMC11036788
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Establishment of tight junctions between cells from different animal species and different sealing capacities

  2005influential reference
• Identification of epithelial cell adhesion molecule autoantibody in patients with ovarian cancer.

  2003cited by this paper
• Epratuzumab: targeting B-cell malignancies through CD22.

  2003cited by this paper
• Preclinical and clinical development of immunocytokines.

  2003cited by this paper
• A recombinant immunotoxin derived from a humanized epithelial cell adhesion molecule-specific single-chain antibody fragment has potent and selective antitumor activity.

  2003cited by this paper
• Expression and targeting of the tight junction protein CLDN1 in CLDN1‐negative human breast tumor cells

  2002cited by this paper
• Autocrine production of interleukin 1beta confers constitutive nuclear factor kappaB activity and chemoresistance in pancreatic carcinoma cell lines.

  2002cited by this paper
• Prognostic significance of Ep‐CAM AND Her‐2/neu overexpression in invasive breast cancer

  2002cited by this paper
• Clostridium perfringens enterotoxin fragment removes specific claudins from tight junction strands : Evidence for direct involvement of claudins in tight junction barrier

  2002influential reference
• In vitro and in vivo activity of MT201, a fully human monoclonal antibody for pancarcinoma treatment

  2002cited by this paper
• Autocrine Production of Interleukin 1β Confers Constitutive Nuclear Factor κB Activity and Chemoresistance in Pancreatic Carcinoma Cell Lines

  2002cited by this paper
• Claudin-based barrier in simple and stratified cellular sheets.

  2002cited by this paper
• Characterization of gene expression profiles in intraductal papillary-mucinous tumors of the pancreas.

  2002cited by this paper
• Imaging immune surveillance by T cells and NK cells

  2002cited by this paper
• Differential expression patterns of claudins, tight junction membrane proteins, in mouse nephron segments.

  2002cited by this paper
• Rituximab as first-line and maintenance therapy for patients with indolent non-Hodgkin's lymphoma: Interim follow-up of a multicenter phase II trial.

  2002cited by this paper
• Assembly of the immunological synapse for T cells and NK cells.

  2002cited by this paper
• Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin.

  2001cited by this paper
• Disseminated cytokeratin positive tumor cells in the bone marrow of patients with prostate cancer: detection and prognostic value.

  2001influential reference
• Variability in B-cell antigen expression: implications for the treatment of B-cell lymphomas and leukemias with monoclonal antibodies.

  2001cited by this paper
• Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses

  2001cited by this paper
• The epithelial glycoprotein 2 (EGP-2) promoter-driven epithelial-specific expression of EGP-2 in transgenic mice: a new model to study carcinoma-directed immunotherapy.

  2001cited by this paper
• Expression of Clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in prostate cancer epithelium.

  2001influential reference
• Heterogeneity in expression and subcellular localization of claudins 2, 3, 4, and 5 in the rat liver, pancreas, and gut.

  2001cited by this paper
• Clinical experience with edrecolomab: a monoclonal antibody therapy for colorectal carcinoma.

  2001cited by this paper
• Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes.

  2001cited by this paper
• Mutations in the gene encoding tight junction claudin-14 cause autosomal recessive deafness DFNB29.

  2001cited by this paper
• Recombinant anti-carcinoembryonic antigen antibodies for targeting cancer

  2000cited by this paper
• The expression of fatty acid synthase (FASE) is an early event in the development and progression of squamous cell carcinoma of the lung.

  2000cited by this paper
• The expression of Ep-CAM (17-1A) in squamous cell cancers of the lung.

  2000cited by this paper
• Ep-CAM overexpression in breast cancer as a predictor of survival.

  2000cited by this paper
• Pores in the Wall

  2000cited by this paper
• Clostridium perfringens enterotoxin binds to the second extracellular loop of claudin‐3, a tight junction integral membrane protein

  2000influential reference
• Radioimmunoguided surgery in colorectal cancer using a genetically engineered anti-CEA single-chain Fv antibody.

  2000cited by this paper
• Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer.

  2000cited by this paper
• Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer.

  2000cited by this paper
• Molecular physiology and pathophysiology of tight junctions I. Tight junction structure and function: lessons from mutant animals and proteins.

  2000cited by this paper
• Tumor–antigen heterogeneity of disseminated breast cancer cells: Implications for immunotherapy of minimal residual disease

  1999influential reference
• Clostridium perfringens Enterotoxin Fragment Removes Specific Claudins from Tight Junction Strands

  1999cited by this paper
• Endothelial Claudin

  1999cited by this paper
• Manner of Interaction of Heterogeneous Claudin Species within and between Tight Junction Strands

  1999cited by this paper
• Ca(2+)-independent cell-adhesion activity of claudins, a family of integral membrane proteins localized at tight junctions.

  1999cited by this paper
• Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands.

  1999cited by this paper
• Ep-Cam levels in prostatic adenocarcinoma and prostatic intraepithelial neoplasia.

  1999cited by this paper
• Occludin and the functions of tight junctions.

  1999cited by this paper
• Trastuzumab, a recombinant DNA-derived humanized monoclonal antibody, a novel agent for the treatment of metastatic breast cancer.

  1999cited by this paper
• Structural and signalling molecules come together at tight junctions.

  1999cited by this paper
• Hunting down the seminal cells of clinical metastases.

  1999cited by this paper
• Expression of potential target antigens for immunotherapy on primary and metastatic prostate cancers.

  1998cited by this paper
• Claudin-1 and -2: Novel Integral Membrane Proteins Localizing at Tight Junctions with No Sequence Similarity to Occludin

  1998cited by this paper
• Levels of expression of CD52 in normal and leukemic B and T cells: correlation with in vivo therapeutic responses to Campath-1H.

  1998cited by this paper
• Immunohistochemical localization of epithelial glycoprotein EGP-2 and carcinoembryonic antigen in normal colonic mucosa and colorectal tumors.

  1998cited by this paper
• Regulation of the movement of solutes across tight junctions.

  1998cited by this paper
• A Single Gene Product, Claudin-1 or -2, Reconstitutes Tight Junction Strands and Recruits Occludin in Fibroblasts

  1998influential reference
• Epithelial Cell Adhesion Molecule (Ep-CAM) Modulates Cell–Cell Interactions Mediated by Classic Cadherins

  1997cited by this paper
• Targeting of renal cell carcinoma with iodine-131-labeled chimeric monoclonal antibody G250.

  1997cited by this paper
• Clostridium perfringens Enterotoxin Utilizes Two Structurally Related Membrane Proteins as Functional Receptors in Vivo *

  1997cited by this paper
• Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases.

  1996cited by this paper
• A small bispecific antibody construct expressed as a functional single-chain molecule with high tumor cell cytotoxicity.

  1995cited by this paper
• New chimeric anti-pancarcinoma monoclonal antibody with superior cytotoxicity-mediating potency.

  1994cited by this paper
• Cellular mucins: targets for immunotherapy.

  1994cited by this paper
• Ep-CAM: a human epithelial antigen is a homophilic cell-cell adhesion molecule

  1994cited by this paper
• Basic local alignment search tool.

  1990cited by this paper
• The epithelial cell surface antigen 17–1A, a target for antibody‐mediated tumor therapy: Its biochemical nature, tissue distribution and recognition by different monoclonal antibodies

  1986cited by this paper
• Antibody density on rat red cells determines the rate of activation of the complement component Cl

  1985cited by this paper
• Antibody density on rat red cells determines the rate of activation of the complement component C1.

  1985cited by this paper

• Identification of claudin-3 as an entry factor for rat hepacivirus

  2025cites this paper
• Antibody-mediated targeting of Claudins in cancer

  2024cites this paper
• Claudins in Cancer: A Current and Future Therapeutic Target

  2024cites this paper
• Identification and characterization of a first-generation inhibitor of claudin-1 in colon cancer progression and metastasis.

  2023cites this paper
• Role of Interleukins in Inflammation-Mediated Tumor Immune Microenvironment Modulation in Colorectal Cancer Pathogenesis

  2023cites this paper
• Claudin and pancreatic cancer

  2023influential citation
• Claudins: The Newly Emerging Targets in Breast Cancer.

  2022cites this paper
• The role of inflammations and EMT in carcinogenesis

  2022cites this paper
• Targeting claudins in cancer: diagnosis, prognosis and therapy.

  2021cites this paper
• The Expression and Prognostic Signi fi cance of Claudin-8 and Androgen Receptor in Breast Cancer

  2020cites this paper
• The Expression and Prognostic Significance of Claudin-8 and Androgen Receptor in Breast Cancer

  2020cites this paper
• Role of Claudin Proteins in Regulating Cancer Stem Cells and Chemoresistance-Potential Implication in Disease Prognosis and Therapy

  2019cites this paper
• Anti-Claudin Antibodies as a Concept for Development of Claudin-Directed Drugs

  2018cites this paper
• Antibody targeting of claudin-1 as a potential colorectal cancer therapy

  2017cites this paper
• Claudin‐targeted drug development using anti‐claudin monoclonal antibodies to treat hepatitis and cancer

  2017cites this paper
• Claudins-4 and -7 might be valuable markers to distinguish hepatocellular carcinoma from cholangiocarcinoma

  2016cites this paper
• Current progress in a second-generation claudin binder, anti-claudin antibody, for clinical applications.

  2016cites this paper
• Generation and characterization of a human-mouse chimeric antibody against the extracellular domain of claudin-1 for cancer therapy using a mouse model.

  2016cites this paper
• Claudin 1 in Breast Cancer: New Insights

  2015cites this paper
• Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery

  2015cites this paper
• Generation of specific monoclonal antibodies against the extracellular loops of human claudin-3 by immunizing mice with target-expressing cells

  2015cites this paper
• Tight junction alkotórészek és mikro RNS expresszió vizsgálata humán daganatokban, különös tekintettel a májdaganatokra

  2015cites this paper
• Immunorécepteurs et épitopes de lymphocytes t spécifiques de la claudine-18.2

  2015cites this paper
• Estrogen-Responsive Genes Overlap with Triiodothyronine-Responsive Genes in a Breast Carcinoma Cell Line

  2014cites this paper
• Polarity proteins as regulators of cell junction complexes: implications for breast cancer.

  2013cites this paper
• Regulation of Tight Junctions for Therapeutic Advantages

  2013cites this paper
• Tricellulin expression in normal and neoplastic human pancreas

  2012cites this paper
• Spiral progression in the development of absorption enhancers based on the biology of tight junctions.

  2012cites this paper
• Claudin-7 expression in hepatocellular carcinoma.

  2012cites this paper
• Creation and biochemical analysis of a broad-specific claudin binder.

  2012cites this paper
• High claudin-7 expression is associated with a poor response to platinum-based chemotherapy in epithelial ovarian carcinoma.

  2011cites this paper
• Challenges associated with the targeted delivery of gelonin to claudin-expressing cancer cells with the use of activatable cell penetrating peptides to enhance potency

  2011cites this paper
• Role of Estrogen Receptor-α in the Regulation of Claudin-6 Expression in Breast Cancer Cells

  2011cites this paper
• Invited Commentary: Role of Estrogen Receptor-α in Regulating Claudin-6 Expression in Breast Cancer Cells

  2011cites this paper
• Title Challenges associated with the targeted delivery of gelonin to claudin-expressing cancer cells with the use of activatable cell penetrating peptides to enhance potency Permalink

  2011cites this paper
• Untersuchung des Zusammenhangs zwischen differentieller Genexpression und phänotypischen Veränderungen solider Karzinome am Beispiel des kolorektalen Karzinoms

  2011cites this paper
• Comparison of six immunohistochemical markers for the histologic diagnosis of neoplasia in Barrett’s esophagus

  2010cites this paper
• Chapter 13 - Claudins in Cancer Biology

  2010cites this paper
• Cloning and expression of C-terminal of Clostridium perfringens type A enterotoxin and its biological activity

  2010cites this paper
• Mitogen-Activated Protein Kinase-Activated Protein Kinases and Metastasis

  2010cites this paper
• Characterization and evaluation of the antitumour activity of a dual-targeting monoclonal antibody against claudin-3 and claudin-4.

  2010cites this paper
• A Novel Screening System for Claudin Binder Using Baculoviral Display

  2010influential citation
• Therapeutic antitumor efficacy of monoclonal antibody against Claudin‐4 for pancreatic and ovarian cancers

  2009cites this paper
• Anticorps contre cldn6

  2009cites this paper
• Development and characterization of a human single-chain antibody fragment against claudin-3: a novel therapeutic target in ovarian and uterine carcinomas.

  2009cites this paper
• Tight Junctions: A Barrier to the Initiation and Progression of Breast Cancer?

  2009cites this paper
• Anticorps anti-claudine-3

  2008cites this paper
• Anti-invasive and Antimetastatic Activities of Ribosomal Protein S6 Kinase 4 in Breast Cancer Cells

  2008cites this paper
• Tight junctions as a target for permeation enhancement

  2007cites this paper
• Differential expression of genes encoding tight junction proteins in colorectal cancer: frequent dysregulation of claudin-1, -8 and -12

  2007cites this paper
• Claudin expression in pancreatic endocrine tumors as compared with ductal adenocarcinomas

  2007cites this paper
• The different structures containing tight junction proteins in epidermal and other stratified epithelial cells, including squamous cell metaplasia.

  2007cites this paper
• Claudin-7 expression in human epithelial ovarian cancer

  2007cites this paper
• Claudin Proteins in Ovarian Cancer

  2007cites this paper
• Distinct claudin expression profile in histologic subtypes of lung cancer.

  2007cites this paper
• Physical mapping of distinct 7q22 deletions in uterine leiomyoma and analysis of a recently annotated 7q22 candidate gene.

  2007cites this paper
• Target discovery and validation in pancreatic cancer.

  2007cites this paper
• Expression profile of tight junction protein claudin 3 and claudin 4 in ovarian serous adenocarcinoma with prognostic correlation.

  2007cites this paper
• Claudin-4 differentiates biliary tract cancers from hepatocellular carcinomas

  2006cites this paper
• Claudin-1 and claudin-2 differentiate fetal and embryonal components in human hepatoblastoma.

  2006cites this paper
• Preparation of a Claudin-Targeting Molecule Using a C-Terminal Fragment of Clostridium perfringens Enterotoxin

  2006cites this paper
• Claudins: multifunctional players in epithelial tight junctions and their role in cancer

  2006cites this paper
• Claudins: emerging targets for cancer therapy

  2006cites this paper
• Claudin expression in Barrett's esophagus and adenocarcinoma

  2005cites this paper
• Claudin proteins in human cancer: promising new targets for diagnosis and therapy.

  2005cites this paper
• Morin for Diagnosis and Therapy Claudin Proteins in Human Cancer : Promising New Targets

  2005cites this paper
• Claudin Expression in Gastric Adenocarcinomas

  2005cites this paper
• Claudin expression in gastric adenocarcinomas: a tissue microarray study with prognostic correlation.

  2005cites this paper
• Biophysical approaches for studying the integrity and function of tight junctions.

  2005cites this paper